Claritev Corporation (NYSE:CTEV) filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting a net loss attributable to the company of $61.8 million for the third quarter.

Key Highlights

  • Revenue of $268.3 million for the three months ended September 30, 2026, up from $245.9 million in the same quarter of 2025, according to the filing.
  • Net loss attributable to Claritev was $61,784 thousand for Q3 2026, compared to $69,753 thousand in Q3 2025.
  • Nine-month net loss attributable to Claritev was $194,570 thousand through September 30, 2026, versus $203,712 thousand in the same period of 2025.
  • Total assets stood at $4,678,553 thousand as of September 30, 2026, compared to $4,888,458 thousand as of December 31, 2025.
  • Total shareholders' deficit widened to $(339,877) thousand as of September 30, 2026, from $(167,175) thousand at December 31, 2025.
  • Long-term debt was $4,602,236 thousand as of September 30, 2026, with an additional $95,000 thousand drawn on the 2025 Revolving Credit Facility.
  • Shares outstanding as of November 2, 2026, were 17,074,785 shares of Class A common stock, par value $0.0001 per share.

Claritev Reports Q3 2026 Operating Results and Balance Sheet Position

According to the filing, Claritev Corporation reported revenues of $268,311 thousand for the three months ended September 30, 2026, an increase from $245,959 thousand in the corresponding quarter of 2025. For the nine months ended September 30, 2026, revenues totaled $770,467 thousand, compared to $718,859 thousand in the first nine months of 2025. The company reported operating income of $20,627 thousand for Q3 2026, up from $10,067 thousand in Q3 2025.

The filing disclosed that interest expense remained a significant cost, totaling $100,904 thousand for the third quarter of 2026, compared to $101,232 thousand in Q3 2025. For the nine-month period, interest expense was $300,699 thousand versus $292,614 thousand in 2025. Net loss per share, basic and diluted, was $(3.64) for Q3 2026, compared to $(4.23) for Q3 2025, based on weighted average shares outstanding of 16,975,211 and 16,480,703, respectively.

The condensed consolidated balance sheet as of September 30, 2026, showed cash and cash equivalents of $10,142 thousand, down from $16,814 thousand at December 31, 2025. Goodwill remained unchanged at $2,405,853 thousand. The accumulated deficit grew to $2,623,990 thousand from $2,429,420 thousand at year-end 2025. The company also disclosed that 44,000 treasury shares were contributed to charity during Q3 2026 in connection with a charitable contribution of treasury stock. The company is classified as an accelerated filer and is incorporated in Delaware, with principal offices in McLean, Virginia.

What Was Disclosed

Claritev Corporation's Form 10-Q for the quarter ended September 30, 2026, disclosed quarterly revenues of $268.3 million, a net loss attributable to the company of $61.8 million, total assets of $4.68 billion, and a total shareholders' deficit of approximately $339.9 million.